MA53138A - 3- (5-HYDROXY-1-OXOISOINDOLINE-2-YL) PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ZINC-2 FINGER-DEPENDENT DISEASES OF THE IKAROS FAMILY (IKZF2) - Google Patents
3- (5-HYDROXY-1-OXOISOINDOLINE-2-YL) PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ZINC-2 FINGER-DEPENDENT DISEASES OF THE IKAROS FAMILY (IKZF2)Info
- Publication number
- MA53138A MA53138A MA053138A MA53138A MA53138A MA 53138 A MA53138 A MA 53138A MA 053138 A MA053138 A MA 053138A MA 53138 A MA53138 A MA 53138A MA 53138 A MA53138 A MA 53138A
- Authority
- MA
- Morocco
- Prior art keywords
- ikzf2
- oxoisoindoline
- piperidine
- finger
- hydroxy
- Prior art date
Links
- JJUMFQGCQAUIFH-UHFFFAOYSA-N 3-(6-hydroxy-3-oxo-1h-isoindol-2-yl)piperidine-2,6-dione Chemical class C1C2=CC(O)=CC=C2C(=O)N1C1CCC(=O)NC1=O JJUMFQGCQAUIFH-UHFFFAOYSA-N 0.000 title 1
- 101000599037 Homo sapiens Zinc finger protein Helios Proteins 0.000 title 1
- 102000039995 Ikaros C2H2-type zinc-finger protein family Human genes 0.000 title 1
- 108091069197 Ikaros C2H2-type zinc-finger protein family Proteins 0.000 title 1
- 102100037796 Zinc finger protein Helios Human genes 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862695920P | 2018-07-10 | 2018-07-10 | |
PCT/IB2019/055804 WO2020012334A1 (en) | 2018-07-10 | 2019-07-08 | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
MA53138A true MA53138A (en) | 2021-05-19 |
MA53138B1 MA53138B1 (en) | 2023-10-31 |
Family
ID=75905122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA53138A MA53138B1 (en) | 2018-07-10 | 2019-07-08 | 3-(5-HYDROXY-1-OXOISOINDOLINE-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2) DEPENDENT DISEASES |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR116110A1 (en) |
MA (1) | MA53138B1 (en) |
-
2019
- 2019-07-05 AR ARP190101914A patent/AR116110A1/en unknown
- 2019-07-08 MA MA53138A patent/MA53138B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR116110A1 (en) | 2021-03-31 |
MA53138B1 (en) | 2023-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL278951A (en) | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases | |
MA51200A (en) | NEW COMPOUNDS AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
MA52003A (en) | TREATMENT METHODS FOR DISEASES ASSOCIATED WITH HPV | |
MA49458A (en) | COMPOUNDS INTERACTING WITH THE RAS SUPERFAMILY FOR USE IN THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES AND FIBROTIC DISEASES | |
MA56392A (en) | 2H-INDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES | |
MA45550A (en) | DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS | |
MA50417A (en) | METHODS OF USING EHMT2 INHIBITORS IN THE TREATMENT OR PREVENTION OF BLOOD DISORDERS | |
MA45089A (en) | USE OF 2-SUBSTITUTE INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES | |
MA52575A (en) | DRESSING FOR THE TREATMENT OF DAMAGED SKIN | |
MA51524A (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASE TISSUES | |
MA55604A (en) | PYRROLOTRIAZINE DERIVATIVES FOR THE TREATMENT OF KIT AND PDGFRA-MEDIATED DISEASES | |
MA43980A (en) | METHODS OF DIAGNOSIS AND PROGNOSIS OF CARDIOVASCULAR DISEASES AND EVENTS | |
MA54515A (en) | QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | |
MA56387A (en) | QUINAZOLIN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH BRAF | |
MA56019A (en) | NEW COMPOUNDS AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
MA52873A (en) | NEW COMPOUNDS AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
MA44762A (en) | SEMAGLUTIDE USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES | |
MA53614A (en) | PROTEIN FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
MA52631A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
MA44935A1 (en) | Pharmaceutical compositions containing an alpha 4 integrin antagonist, used for the treatment of inflammatory conditions of the eye | |
MA50905A (en) | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES | |
MA54077A (en) | POLYTHERAPY FOR THE TREATMENT OF BLOOD DISEASES | |
MA53873A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | |
MA53739A (en) | COMPOSITION AND USE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS | |
MA49884A (en) | IMIDAZO [4,5-C] QUINOLIN-2-ONE DEUTERATES AND THEIR USE IN THE TREATMENT OF CANCER |